MedTrace Logo

Tango for Older People With Dementia

NCT05744011 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 124

Last updated 2023-02-24

No results posted yet for this study

Summary

Cognitive impairment (CI) is the leading cause of loss of autonomy and has a huge impact on physical performance and quality of life (QOL) in older people. Pharmacological treatments currently available have modest efficacy at best. Dance as both artistic and physical activity, combining emotions, social interaction, and sensory stimulation, therefore appears as a non-pharmacological intervention, which could contribute to the prevention of functional decline.

Among all the existing dances, tango occupies a special place because of the cultural and emotional resonance it carries, but also because of what it leads to motor mobilization (variations in the rhythm of walking, rotation of the belts, weight transfers…). These characteristics seem to make the tango an excellent tool for the rehabilitation of balance and gait, as well as for the prevention of the loss of autonomy in older adults with CI.

The objective of this study is to evaluate and compare the effectiveness of an intervention based on tango and classical physical activity.

Conditions

  • Old Age; Dementia

Interventions

OTHER

Tango intervention

The interventions will be implemented by ABB Reportages and will be carried out by nursing staff who had previously received training in therapeutic tango at the University of Burgundy. A dance movement therapist and a musician will accompany the interventions twice a month. Participants will attend a 1-hour tango session, twice a week for twelve weeks.

OTHER

Adapted Physical Activity

The intervention will be carried out by an Adapted Physical Activity professor and by nursing staff. Music is prohibited during the sessions. Participants will attend a 1-hour APA, twice a week for twelve weeks.

Sponsors & Collaborators

  • University of Burgundy

    lead OTHER

Principal Investigators

  • France Mourey, Professor · Inserm U1093, University of Burgundy

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-06-16
Completion
2023-09-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05744011 on ClinicalTrials.gov